Are you Dr. Yates?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 68 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3131 La Canada St
Ste 140
Las Vegas, NV 89169Phone+1 702-933-9400Fax+1 702-933-9444
Summary
- Dr. Steven Yates, MD is an oncologist in Las Vegas, Nevada. He is currently licensed to practice medicine in Nevada, North Carolina, and Wisconsin.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1990 - 1993
University of Kentucky College of MedicineResidency, Internal Medicine, 1987 - 1990
Virginia Commonwealth University School of MedicineClass of 1987
Certifications & Licensure
NV State Medical License 2018 - 2025
NC State Medical License 1993 - 2019
WI State Medical License 1990 - 1993- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Publications & Presentations
PubMed
- 254 citationsPhase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.Mark A. Socinski, Michael J. Schell, Amy H. Peterman, Kamal Bakri, Steven Yates
Journal of Clinical Oncology. 2002-03-01 - 45 citationsSecond-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.Mark A. Socinski, Michael J. Schell, Kamal Bakri, Amy H. Peterman, Ji-Hyun Lee
Cancer. 2002-09-15
Press Mentions
Crossbreeding of Holstein Cows Improves Fertility Without Detriment to Milk ProductionAugust 24th, 2020
How Has the on-Demand Industry Coped with the Coronavirus?April 9th, 2020
Professional Memberships
- Member
